Does VEDOLIZUMAB Cause Vaginal flatulence? 174 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Vaginal flatulence have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.2% of all adverse event reports for VEDOLIZUMAB.
174
Reports of Vaginal flatulence with VEDOLIZUMAB
0.2%
of all VEDOLIZUMAB reports
0
Deaths
135
Hospitalizations
How Dangerous Is Vaginal flatulence From VEDOLIZUMAB?
Of the 174 reports, 135 (77.6%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Vaginal flatulence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Vaginal flatulence?
METRONIDAZOLE (230)
ACETAMINOPHEN (219)
HYDROMORPHONE (218)
ADALIMUMAB (207)
SULFAMETHOXAZOLE\TRIMETHOPRIM (205)
MESALAMINE (198)
MORPHINE (191)
HYDROCORTISONE (184)
BISACODYL (182)
ATORVASTATIN (181)
Which VEDOLIZUMAB Alternatives Have Lower Vaginal flatulence Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB